Effect of donor age and sex on the outcome of liver transplantation by Marino, IR et al.
Effect of Donor Age and Sex on the Outcome 
of Liver Transplantation 
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TIMOTHY GAYOWSKI,l,2 JOHN J. FUNG,lANDREAS G. TZAKIs,1,3 AND THOMAS E. STARZL1,2 
We correlated donor and recipient factors with graft 
outcome in 436 adult patients who underwent 462 liver 
transplants. Donor variables analyzed were age, gender, 
ABO blood group, cause of death, length of stay in the 
intensive care unit, use of pressors or pitressin, need for 
cardiopulmonary resuscitation, terminal serum trans-
aminases, and ischemia time. Recipient variables ana-
lyzed were age, gender, primary diagnosis, history of 
previous liver transplant, ABO blood group, cytotoxic 
antibody crossmatch, United Network for Organ Shar-
ing (UNOS) status, and waiting time (except for the 
cross-match results, they were all known at the time of 
the operation). The endpoint of the analysis was graft 
failure, defined as patient death or retransplantation. 
Using multivariate analysis, graft failure was signifi-
cantly associated with donor age, donor gender, previ-
ous liver transplantation, and UNOS 4 status of the re-
cipient. The effect of donor age became evident only 
when they were older than 45 years. Livers from female 
donors yielded significantly poorer results, with 2-year 
graft survival of female to male 55% (95% CI, 45% to 67%); 
female to female, 64% (95% CI, 54% to 77%); male to male, 
72% (95% CI, 66% to 78%); and male to female, 78% (95% 
CI, 70% to 88%). The only donors identified as question-
able for liver procurement were old E~SM years) women 
in whom the adverse age and gender factors were at 
least additive. However, rather than discard even these 
livers, in the face of an organ shortage crisis, their indi-
vidualized use is suggested with case reporting in a spe-
cial category. (HEPATOLOGY 1995;22:1754-1762.) 
As of January 4,1995,37,751 transplant candidates 
were registered on the national waiting list operated 
by the United Network for Organ Sharing (UNOS), the 
agency that coordinates organ allocation in the United 
States. This was a 391 % increase from the 9,632 wait-
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ing in December 1986. Of the 37,751 in 1995, 4,039 
were liver candidates, up from 449 in 1987 (a 900% 
increase). The supply of all organ donors had under-
gone a marginal increase between 1988 and 1990 (from 
4,085 to 4,514), but has remained relatively stable since 
then: 4,531 in 1991, 4,521in 1992, 4,849 in 1993, and 
4,891 in 1994. 
The limited supply of organ donors has increasingly 
influenced the selection of candidates for liver trans-
plantation, and is used at some institutions to justify 
restricting the availability of the procedure.1 Although 
the exact magnitude of the organ deficit is not yet 
known,2,3 the obvious gap between supply and need has 
stimulated the development of bioartificialliver assist 
devices,4 utilization of living related liver donors,5,6 use 
of non-heart beating donors,7'9 and xenotransplanta-
tion. 10 A more immediate impact on organ shortage 
already has come from the widespread use of livers 
from "marginal donors," as first documented by Ma-
kowka et all! and Pruim et al. 12 
The definition of a marginal donor has varied in dif-
ferent reports, and recently has included obesity.13,14 
Two potential risk factors-age and gender-are rele-
vant with all donors, no matter what the other circum-
stances of death. Although it has long been thought 
that the liver is less affected than other organs by se-
nescence,15,16 poor experience with older donors in the 
original Denver series (including two who were 73 
years of age) resulted in an upper donor age limitation 
of 45 years. 17 The demonstration that satisfactory liv-
ers could be obtained from donors well into the seventh 
decade of life18,19 or beyond20 was followed by a flurry 
of confirmatory reports,13,14,21,22 countered by descrip-
tions of degraded results using geriatric livers. 23-26 
Less has been written about the effect of donor sex 
on outcome after liver transplantation, although there 
is an extensive literature, recently summarized by 
Neugarten and Silbiger,27 showing poorer results with 
kidney allografts from female donors. We have reported 
similar findings with female livers in adults28,29 but not 
in children.30 The gender effect has been disputed by 
Stratta et al.31 
In the current study, we have examined with univari-
ate and multivariate analyses the effect on outcome of 
donor age and sex, singly and together, in a consecutive 
series of liver recipients, taking into account an array 
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of other risk factors. A clear influence of both donor 
age and gender on outcome was identifiable. 
PATIENTS AND METHODS 
From January 1, 1992 to June 30, 1993, 436 consecutive 
adult patients received 479 liver transplants at the Univer-
sity of Pittsburgh Medical Center and the Veterans Adminis-
tration Medical Center, Pittsburgh, P A. The livers in 17 were 
part of multivisceral transplants that included intestine. 
These cases were excluded, leaving 419 recipients of 462 allo-
grafts who were entered for analysis. The information was 
obtained from the clinical database maintained by the Pitts-
burgh Transplantation Institute, and a review of the donor 
charts that are kept on file at the Center for Organ Recovery 
and Education (Western Pennsylvania Organ Procurement 
Organization) Pittsburgh, PA. 
All grafts were flushed with the University of Wisconsin 
solution. No attempt was made to transplant older livers into 
older recipients, or vice versa. ABO compatibility, size match, 
and medical urgency tUNOS status, see later discussion), 
were the only criteria used in recipient selection. All recipi-
ents were treated with the same immunosuppressive proto-
col, based on tacrolimus (Prograf, formerly FK506, Fujisawa 
USA, Inc., Deerfield, IL) and prednisone, augmented by aza-
thioprine and antilymphocyte globulin in a small minority 
of cases. Intravenous prostaglandin El was routinely given 
perioperatively.32 
Variables Studied 
Donors. Age, gender, ABO blood group, cause of death, 
length of stay in the intensive care unit, need for pressors or 
pitressin, need for cardiopulmonary resuscitation, terminal 
serum transaminases (alanine transaminase and aspartate 
transaminase), and ischemia time were studied. 
Recipients. Recipient variables included age, gender, diag-
nosis, history of previous liver transplant, ABO blood group, 
UNOS status, waiting time, results of the cytotoxic cross-
match, patient and graft survival times, and cause of graft 
failure. The indications for orthotopic liver transplantation 
were collapsed into seven diagnostic categories (Table 1). In 
the case of a retransplantation, the diagnosis was the cause 









TABLE 1. Diagnostic Categories 
Diagnoses 
Hepatitis B, hepatitis C, and non-A, non-B, 
non-C 
PBC, PSC, cystic fibrosis, secondary biliary 
cirrhosis, biliary atresia, etc. 
All other diagnoses excluded 
Ethanol-induced drrhosis 
Primary or secondary 
Primary nonfunction and late failures due 
to harvest injury 
Budd-Chiari syndrome, sarcoidosis, 
fulminant failure, etc. 
Abbreviations: PBC, primary biliary cirrhosis; PSC, primary scle-
rosing cholangitis. 
* The category "Other" encompasses diagnoses with 10 or fewer 
observations. 
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Definitions 
Graft Failure. Patient death or retransplantation at any 
time during follow-up was considered a graft failure. A sepa-
rate analysis also was made of "early failures" within 90 days 
of transplantation. Primary nonfunction, a subcategory of 
early failure, referred to a graft that had such poor initial 
function that retransplantation or death occurred within 2 
weeks. Failures attributable to technical errors were not con-
sidered as primary nonfunction. 
Severe Ischemic Injury. Severe ischemic injury referred to 
damage of the allograft, either before revascularization or 
afterward, that did not have a demonstrable immunologic 
cause. Causes of the damage included hemodynamic or toxic 
insults in the donor; injury during harvesting, transport, or 
on the back table; and recipient cardiovascular instability 
after revascularization. For the purposes of analysis, organs 
lost to primary nonfunction or ischemic injury are grouped 
together. 
Medical Urgency. Medical urgency was rated as follows: 
UNOS 1: patient stable at home; UNOS 2: waiting at home, 
but requiring medical support; UNOS 3: unstable, in need 
of continuous hospitalization; UNOS 4: requirement of life-
support systems. 
Waiting Time. Waiting time was the number of days be-
tween acceptance on the UNOS waiting list and the day of 
the transplantation. 
Ischemia Time. Ischemia time was the time elapsed from 
aortic cross-clamping in the donor to portal or arterial revas-
cularization in the recipient. 
Need for Pressors. Dopamine infusion > 10 ~g/kg/minI or 
need for a continuous infusion, at any dose level, of epineph-
rine or norepinephrine was classified as a need for pressors. 
Statistical Analysis 
Univariate. Continuous variables are presented as the 
mean ± SEM, and categorical variables as rates. For continu-
ous variables, two-tailed t-tests determined whether there 
was a difference between groups. Pearson's X2 for 2 X k tables 
tested for association in categorical variables. If an associa-
tion was found in variables containing more than two catego-
ries, a Tukey-Kramer multiple comparisons procedure on k 
groups with Bernoulli responses33 was used to identify the 
individual categories that were significantly different. The 
Mantel-Haenzel test was used to control for confounding vari-
ables. The level of significance for all tests was set at .05. 
Multivariate. Variables found with univariate analyses to 
be associated with outcome, or whose association was ofbor-
derline significance, were then used in a stepwise logistic 
regression analysis to identify the variables that are indepen-
dent predictors of outcome. In the case of categorical vari-
ables, preliminary univariate logistic regression models were 
fit to determine if subcategories should be grouped together. 
Models were fit using both forward inclusion and backward 
elimination, with a likelihood ratio test to determine which 
variables were to remain in the model after each iteration. 
A significance level of .1 was used in the stepwise procedure. 
To further explore the relationship between donor age and 
graft outcome, a generalized additive mode134 was fit, using 
the four variables identified during the stepwise logistic re-
gression analysis (see Results). Three ofthese variables were 
categorical and were coded as either 0 (absent) or 1 (present). 
Donor age was entered into the model as a continuous mea-
sure, using a local regression procedure. 35 Once the functional 
relation between donor age and the probability of graft failure 
was determined, it was possible to calculate pointwise stan-
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dard errors on the predicted probabilities by fitting a general-
ized linear model,36 substituting a regression spline for the 
smooth age term (see Results). Pointwise confidence intervals 
were calculated using a Bonferroni adjustment. 
Survival. The Kaplan-Meier method was used, with differ-
ences between curves determined by means of the log rank 
test. 
The univariate analyses and stepwise logistic regression 
procedure were performed using SPSS (SPSS Inc., Chicago, 
IL). All other procedures were performed using S-Plus (Stat 
Sci, Seattle, WA). 
RESULTS 
Univariate Analysis 
The 419 recipients of 462 livers were followed for 
1.12 to 2.6 years. Of the 462 livers, 452 were trans-
planted alone, and the other 10 were combinations with 
a kidney (n = 4), bone marrow (n = 4), heart (n = 1), 
and pancreatic islets (n = 1). The only ABO mismatch, 
A ---+ 0, was successful. Of the 144 graft losses (31.2%) 
during the study period, 84 (18.2%) were within the 
first 90 days. 
Recipient Risk Factors. Allograft losses were almost 
threefold more common after retransplantation, and 
significantly more frequent when the recipient was in 
the UNOS 4 category (Table 2). Waiting times were 
longer in the successful group, presumably reflecting 
their more elective status, but this fell short of statisti-
cal significance CP = .067). 
Donor Risk Factors. Only two variables were statis-
tically associated with outcome: donor age and donor 
TABLE 2. Recipient Characteristics 
According to Graft Outcome 
Successful Failed 
Grafts Grafts 
(n = 318) (n = 144) 
Age (yrs) 51.3 ± 0.7 50.3 ± 1 
Gender (MIF) 200/118 99/45 
Previous OLTx (%) 10.4 28.5 
Diagnosis (%): 
Alcoholic 17.3 15.3 
Cholestatic 19.5 17.4 
Cryptogenic 10.7 10.4 
Ischemic injury 3.1 9.0 
Malignancy 6.3 7.6 
Posthepatitic 29.6 28.5 
Other 13.5 11.8 
UNOS status (%): 
Status 2 17.9 8.3 
Status 3 45.3 36.8 
Status 4 36.8 54.9 
Waiting time (days) 160 ± 16 111 ± 17 
Positive cross-match (%) 10.7 9.1 
* No difference across diagnostic categories. 
NS 
NS 
P < .00001 
NS* 
P = .0005t 
P = .067 
NS 
t Overall P value for differences in UNOS status. When individual 
comparisons are made between groups, status 2 and 3 are signifi-
cantly different from status 4. Status 2 is not different from status 
3. 
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TABLE 3. Donor Characteristics 
According to Graft Outcome 
Successful Grafts Failed Grafts 
(n = 318) (n = 144) 
Age (yrs) 37.2 ± 0.8 43.9 ± 1.4 P < .001 
Gender (MIF) 217/101 76/68 P = .0014 
Cause of death (%): 
Anoxia 6.6 9.8 
Closed head illdury 9.5 7.7 
Stroke 37.5 43.4 
Trauma'" 32.8 27.3 
Other 13.6 11.9 NSt 
CPR (%) 16.9 17.5 NS 
Need for pressors (%) 40.2 40.1 NS 
Need for pitressin (%) 29.6 34.3 NS 
ICU LOS (days) 3.3 ± 0.2 4.1 ± 0.6 NS 
Terminal AST (lUlL) 76.6 ± 5 69.1 ± 5 NS 
Terminal ALT (lUlL) 51.5 ± 4 47.2 ± 3.6 NS 
Ischemia time (hr) 13.2 ± 0.2 13.5 ± 0.3 NS 
Abbreviations: CPR, cardiopulmonary resuscitation; ICU LOS, 
length of stay in intensive care unit. 
* Includes multiple trauma and gunshot wounds to the head. 
t No difference across all causes of death categories. 
gender (Table 3). This already was evident within the 
first 3 months (data not shown). 
Multivariate Analyses 
Those variables found to be significant, or of border-
line significance, in the univariate analysis provided 
the starting points for stepwise logistic regression anal-
yses. 
Graft Losses Before 90 Days. Three variables (two re-
cipient, one donor) were identified as independent pre-
dictors of outcome: prior transplantation (odds ratio, 
3.02; 95% cr, 1.68 to 5.45), UNOS 4 status (odds ratio, 
1.56; 95% cr, 0.93 to 2.62), and donor age (odds ratio 
for an increase of 10 years, 1.34; 95% cr, 1.14 to 1.57). 
A gender factor was not significant. 
Graft Losses in Total Study Period. Four variables 
(two recipient and two donor) were identified as inde-
pendent predictors of graft failure during the 1.12 to 
2.6 years offoUow-up: UNOS 4 status (odds ratio, 1.58; 
95% cr, 1.02 to 2.44), prior transplantation (odds ratio, 
2.86; 95% cr, 1.65 to 4.93), female donor sex (odds ratio, 
1.5; 95% cr, 0.97 to 2.32), and donor age (odds ratio for 
an increase of 10 years, 1.26; 95% cr, 1.1 to 1.44). 
The Age Factor. Donors were stratified into those 60 
years of age or older (n = 54) and those younger than 
this (n = 408). Older donors E~SM years) were more 
likely to be females (28 females, vs. 20 expected), had 
lower terminal transaminases, and were more likely to 
die of a stroke than from trauma or "other" causes (Ta-
ble 4). Recipients of the old organs had a positive cross-
match with 1.9% of their donors compared with 11.3% 
in the recipients of younger organs (P = .03) (Table 5). 
Figure 1 shows the Kaplan-Meier graft survival 
curves. At 23 months, graft survival in the younger 
donor cohort was 0.71 (95% cr, 0.66 to 0.76), whereas 
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TABLE 4. Donor Characteristics According to Donor Age 
Young Donors Old Donors 
«60 years, (".60 years, 
n = 408) n = 54) 
Age (yrs) 35.9 :!: 0.7 65.2 ::+:: 0.6 P < .001 
Gender (MIF) 267/141 26/28 P = .013 
Cause of death (%): 
Anoxia 7.4 9.3 
Closed head injury 9.4 5.6 
Stroke 34.7 74.1 
Trauma* 34.7 3.7 
Other 13.8 7.4 P < .00001t 
CPR(%) 17.9 11.3 NS 
Need for pressors 
(%) 40.8 35.8 NS 
Need for pitressin 
(%) 32.2 22.6 NS 
!CU LOS (days) 3.6 ::+:: 0.3 3.1 :!: 0.4 NS 
Terminal AST (IUIL) 77 :!: 4.2 53::+:: 5.5 P = .001 
Terminal ALT (IUIL) 52::+:: 3.3 36 ::+:: 3.5 P = .001 
Ischemia time (hr) 13.4 ::+:: 0.2 12.8 ::+:: 0.6 NS 
Abbreviations: CPR, cardiopulmonary resuscitation; ICU LOS, 
length of stay in intensive care unit. 
* Includes multiple trauma and gun shot wounds to the head. 
t Overall P value across all cause of death categories. When indi-
vidual comparisons are made between groups, stroke is significantly 
different from both trauma and "other." 
for the older donor group it was 0.52 (95% cr, 0.39 to 
0.65), a difference that is highly significant (P = .0001). 
However, this difference was only modestly reflected 
in the Kaplan-Meier patient survival (Fig. 2). At the 
23-month milestone, 0.78 of recipients of young livers 
were still alive (95% cr, 0.74 to 0.82) compared with 
0.71 of recipients of geriatric livers (95% cr, 0.59 to 
0.84) (P = .037). 
Figure 3 shows the predicted probability of graft fail-
TABLE 5. Recipient Characteristics According to Donor Age 
Young Donors Old Donors 
«60 years, (".60 years, 
n = 408) n = 54) 
Age (yrs) 50.6::+:: 0.6 53.8:!: 1.4 P = .065 
Gender (MIF) 262/146 37/17 NS 
Previous OLTx (%) 15.4 20.4 NS 
Diagnosis (%): 
Alcoholic 16.9 14.8 
Cholestatic 18.1 24.1 
Cryptogenic 10.0 14.8 
Ischemic injury 5.4 1.9 
Malignancy 6.9 5.6 
Posthepatitic 29.7 25.9 
Other 13.0 13.0 NS 
UNOS status (%): 
Status 2 14.7 16.7 
Status 3 42.9 40.7 
Status 4 42.4 42.6 NS 
Waiting time (days) 141 :!: 13 174::+:: 34 NS 
Positive cross-match (%) 11.3 1.9 P = .03 
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FIG. 1. Kaplan-Meier graft survival curves of "older" and 
"younger" donor livers. The numbers on the curves indicate the popu-
lation at risk. 
ure as a function of donor age, assuming that the re-
maining risk factors identified in this study are absent 
(i.e., not a retransplantation, not UNOS 4, and male 
donor). Donor age was entered into this model as a 
smooth term, using a local regression procedure that 
fits a regression function to the data. This procedure 
is nonparametric, requiring no prior knowledge of the 
functional relationship between the predictors and the 
response variable,35 thus allowing for flexible explora-
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FIG. 2. Kaplan-Meier patient survival curves in recipients of 
"older" and "younger" donor livers. The numbers on the curves indi-
cate the population at risk. 
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FIG. 3. Expected probability of graft failure as a function of donor 
age (solid line). This assumes that the organs come from male donors, 
the recipients are not UNOS 4, and it is not a retransplantation. 
The dashed lines indicate 2 standard errors around the estimated 
values (thereby closely approximating a continuous 95% confidence 
band). 
until a donor age of approximately 45 years, at which 
point the risk of failure began to increase significantly. 
This was also supported by the fact that donor age was 
not an independent predictor when fitting a logistic 
regression model on the subset of the data containing 
only donors 45 years of age or younger, but did come 
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FIG. 4. Kaplan-Meier graft survival curves according to donor-
recipient sex combination. The numbers on the curves indicate the 
population at risk. MF = Male to Female. MM = Male to Male. FF 
= Female to Female. FM = Female to Male. 
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TABLE 6. Graft Survival According to Donor-Recipient 
Gender Combination 
Female to female 
Female to male 
Male to female 
Male to male 
No. of 2-Year Survival Observed Expected 
Grafts (95% cn Failures Failures 
71 0.64 25 21.6 
(0.54-0.77) 
98 0.55 43 27.9 
(0.45-0.67) 
92 0.78 20 30.7 
(0.70-0.88) 
201 0.72 56 63.8 
(0.66-0.78) 
NOTE. P = .004 when comparing across groups . 
data containing only donors older than 45 years (data 
not shown). 
A limitation of this exploratory technique is that it 
does not readily allow calculation of pointwise standard 
errors, necessary for confidence interval estimation. 
However, this can be done indirectly, by substituting 
into a generalized linear model a regression spline that 
closely approximates the curve that was first derived 
from the data. Doing this, the calculated probability of 
graft failure for a 20-year-old donor was 0.16 (95% CI, 
0.08 to 0.24), that of a 40-year-old donor 0.18 (95% CI, 
0.11 to 0.25), and that ofa 65-year-old donor, 0.36 (95% 
CI, 0.23 to 0.49). Analysis of deviance of the final fitted 
model (using a X2 test) showed that all four terms were 
significant: previous transplantation, P = .000002; 
UNOS 4, P = .02; donor gender, P = .005; and donor 
age, P = .002. 
The Gender Factor. Figure 4 shows the Kaplan-
Meier graft survival curves with all four donor-recipi-
ent gender combinations. Graft survival was best with 
male donor to female recipient transplantation and 
worst with female to male recipient (see also Table 
6). Male recipients of female livers also had reduced 
survival, but these trends did not reach statistical sig-
nificance (Table 7), reflecting an aggressive policy of 
retransplantation. 
The female donors were older than the male donors, 
received pitressin less frequently, and had a higher 
TABLE 7. Patient Survival According to Donor-Recipient 
Gender Combination 
Female to female 
Female to male 
Male to female 
Male to male 
No. of 2-Year Survival Observed Expected 
Grafts (95% CIl Failures Failures 
62 0.82 11 14.4 
(0.73-0.92) 
83 0.66 26 17.7 
(0.55-0.79) 
83 0.82 14 19.9 
(0.74-0.92) 
191 0.77 44 43 
(0.71-0.83) 
NOTE. P = .09 when comparing across groups. 
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TABLE 8. Donor Characteristics According to Donor Gender 
Male Donors Female Donors 
(n = 293) (n = 169) 
Age (yrs) 36 ::+: 0.9 45 ::+: 1.1 P < .001 
Cause of death (%): 
Anoxia 4.8 12.5 
Closed head injury 10.3 6.5 
Stroke 31.8 52.4 
Trauma* 40.4 14.9 
Other 12.7 13.7 P < .0000lt 
CPR (%) 15.4 20.1 NS 
Need for pressors 
(%) 40.9 39.0 NS 
Need for pitressin 
(%) 34.8 24.5 P = .03 
ICU LOS (days) 3.5 ::+: 0.2 3.6 ::+: 0.5 NS 
Terminal AST (lUlL) 75 ::+: 4.5 73 ::+: 6.9 NS 
Terminal ALT (lUlL) 52::+: 3.6 46 ::+: 5.2 NS 
Ischemia time (hr) 13.5 ::+: 0.2 13.0 ::+: 3.7 NS 
Abbreviations: CPR, cardiopulmonary resuscitation; ICU LOS, 
length of stay in intensive care unit. 
* Includes multiple trauma and gunshot wounds to the head. 
t Overall P value across all cause of death categories. When indi-
vidual comparisons are made between groups, anoxia and stroke are 
significantly different from trauma. 
incidence of anoxia and stroke but a lower incidence of 
trauma as the cause of death (Table 8). 
Table 9 shows the recipient characteristics according 
to donor gender. Among recipients of female livers, 
there were proportionally more UNOS 4 status than 
UNOS 3 recipients (84 status 4 vs. 72 expected, and 60 
status 3 vs. 72 expected). There were also proportion-
TABLE 9. Recipient Characteristics 
According to Donor Gender 
Male Donors Female Donors 
(n = 293) (n = 169) 
Age (yrs) 50.5 ::+: 0.7 51.9::+: 0.9 
Gender (MIF) 201/92 98/71 
Previous OLTx (%) 14.7 18.3 
Diagnosis (%): 
Alcoholic 18.4 13.6 
Cholestatic 20.5 16.0 
Cryptogenic 10.9 10.1 
Ischemic injury 4.1 6.5 
Malignancy 7.2 5.9 
Posthepatitic 28.0 31.4 
Other 10.9 16.6 
UNOS status (%): 
Status 2 15.0 14.8 
Status 3 46.8 35.5 
Status 4 38.2 49.7 
Waiting time (days) 142 ::+: 14 149 ::+: 23 
Positive cross-match (%) 10.7 9.5 
* Across diagnostic categories. 
NS 
P = .02 
NS 
NS* 
P = .04t 
NS 
NS 
t Overall P values for differences in UNOS status. When individ-
ual comparisons are made between groups, status 3 is significantly 
different from status 4. Status 2 is not different from status 3 or 4. 
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TABLE 10. Cause of Graft Failure 
According to Donor Age Group 
Young Donors Old Donors 
«60 years, n = 408) (",,60 years, n = 54) 
Rejection* 7.3 8.0 
Technical 9.2 8.0 
Ischemic injuryt 22.0 52.0 
Sepsis 30.3 16.0 
Hepatitis 5.5 0 
Cardiovascular 8.3 0 
Other 17.4 16.0 NSt 
NOTE. Expressed as percentages. 
* Includes acute and chronic rejection. 
t Includes primary nonfunction and delayed failures because of 
harvesting injury. 
t Across all failure categories. 
ally fewer female to male (98 observed vs. 109 expected) 
and male to female (92 observed vs. 103 expected) 
transplantations performed (P < .05 for all compari-
sons). 
The Mantel-Haenzel test was used to control for con-
founding variables and provide further confirmation of 
the effect of donor sex on overall graft survival. Donor 
sex was still found to be significantly associated with 
outcome when controlling for prior transplant (P 
= .0034), UNOS status (P = .0064), and recipient sex 
(P = .0012). 
Of 28 livers taken from females who were 60 years 
of age or older, 18 (64.3%) failed, compared with 11 
(42.3%) of 26 when grafts were from geriatric male 
donors (P = .1). 
The causes of graft failure according to donor age are 
shown in Table 10, and grouped according to donor sex 
in Table 11. There were no gender-associated (P = .21) 
differences. Although half of the failures in the older 
donor group were due to ischemic injury, this narrowly 
failed to reach statistical significance (P = .07). 
DISCUSSION 
In general confirmation of the earlier study by Ma-
kowka et al,l1 donor variables such as cause of death, 
TABLE 11. Cause of Graft Failure 
According to Donor Gender 
Male Donors Female Donors 
(0 = 293) (n = 169) 
Rejection* 9.6 4.9 
Technical 6.8 11.5 
Ischemic injuryt 31.5 23.0 
Sepsis 27.4 27.9 
Hepatitis 6.8 1.6 
Cardiovascular 5.5 8.1 
Other 12.4 23.0 
NOTE. Expressed as percentages. 
* Includes acute and chronic rejection. 
NSt 
t Includes primary nonfunction and delayed failures caused by 
harvesting injury. 
t Across all failure categories. 
~~-------------
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length of intensive care unit stay, use of pressors or 
pitressin, and serum transaminases were not associ-
ated with degraded graft survival. The absence of the 
previously reported correlation between ischemia time 
and outcome37 was explained by a concerted effort 
throughout the study period to keep cold ischemia 
within the "safe" window of 18 hours. 
In contrast, older donor age and female gender were 
significant risk factors. Although it is indisputable that 
function of the kidneys decrease with increasing 
age,38,39 such data on liver function and physiology are 
often contradictory.4o Decreases in organ weight and 
liver blood flOW 16.41 are the best documented age-re-
lated alterations, but because of the liver's great func-
tional reserve and the ability to regenerate, these 
changes do not correlate well with functional deteriora-
tion when there is no concomitant pathology.40 
The extent of liver vulnerability after the age of 45 
years was unmasked more decisively with hepatic 
transplantation than by any physiologic test. The 23-
month graft survival using donor livers 60 years of age 
or older was remarkably different than with livers from 
donors younger than 60: 52% versus 71% (P = .0001), 
with patient survival of 71% versus 78% (P = .037). 
These results could not be attributed either to differ-
ences in the recipient populations or to less stringent 
selection criteria on the part of our surgeons on call 
who, if anything, were more cautious when considering 
an older donor. 
The causes of death differed between the older than 
and younger than 60 donors, with a disproportionate 
number of older donors dying of strokes. However, the 
cause of death had no association with outcome in the 
total case collection (Table 3). The most important con-
tributory factor to the high failure rate of the over-
60 livers was overrepresentation of females (28, vs. 20 
expected, P = .013): the 2-year graft failure was 64.3% 
with these female livers, compared with 42.3% with 
older male organs. When all of the other significant 
risk factors (including donor gender) were controlled, 
however, a realistic impression of the age effect 
emerged. The rate of graft failure remained level until 
donor age reached 45, doubled from age 40 to age 65, 
and increased at an accelerated rate thereafter (Fig. 
3). The dashed lines on Fig. 3 encompass a band that is 
2 standard errors around the estimated values, which 
closely approximates a 95% confidence band. The 
bands are extremely wide on both ends of age spectrum 
because of the sparcity of data in these regions. 
The influence of donor sex on the outcome of liver 
transplantation has received little attention in spite of 
the extensive literature on renal transplantation show-
ing inferior results with female donors27 except when 
there was HLA compatibility.27,42 The disarming of the 
adverse gender influence by histocompatibility match-
ing in the kidney experience suggested a gender-re-
lated immunologic factor such as increased graft 
antigenicity not directly attributable to H-Y minor his-
tocompatibility antigen. This hypothesis is strength-
ened by our observations in liver recipients in whom 
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the gender effect was enduring, although not identifi-
able within 90 days. 
The addition of the liver observations to previous 
observations in kidney recipients is compatible with 
the possibility of a sex hormone (or receptor) linkage 
to HLA expression, while weakening alternative expla-
nations for the gender effect on the renal recipient pop-
ulation. 27 These alternative hypotheses included a 
nephron mass/functional demand disproportion caused 
by the systematic use of smaller female donors, and 
a special susceptibility of the female kidney to 
cyclosporine nephrotoxicity. In our liver transplant ex-
perience, also paralleling the earlier kidney studies, 
the double jeopardy was evident of female sex and older 
donor age. In a further similarity, the causes of death 
of the high-risk old female donors included a dispropor-
tionate number of nontraumatic cerebrovascular acci-
dents. 
Earlier reports from Pittsburgh describing a gender 
effect in liver transplantation28.29 were met with incre-
dulity because confounding donor and recipient risk 
variables were not controlled. In the current multivari-
ate analysis, which did not have this defect, the adverse 
female donor influence was pervasive, without regard 
for UNOS status, prior transplantation, recipient sex, 
a positive cytotoxic cross-match, and other factors. The 
lack of a deleterious effect from positive cross-match 
described in our earlier experience43 reflected the rou-
tine prophylactic administration perioperatively of 
prostaglandin-high-dose prednisone. Takaya et aP2 
have shown that this treatment can convert the other-
wise degraded prognosis in such cases43 to that of the 
cross-match negative patient if the antibody titer is 
:s 11512. 
It should be emphasized that the current report is 
only a step in the development of a risk assessment 
model. 44 The confidence bands around the risk facing 
most subgroups were large. This can be improved by 
refining the model and by accrual and study of more 
cases. This will be particularly important for the cur-
rently small numbers of ====60-year livers Conly 11. 7% of 
the total), for which the less desirable female gender 
appeared to weigh more heavily than age. Among the 
over-60 donors, there is a marginally significant (P 
= .1) difference between males and females. A strict 
interpretation (using the .05 criterion) would indicate 
no interaction. However, a trend is certainly indicated. 
The most elementary explanation is that the sample 
size is not sufficient to yield statistical significance. 
Even if the eonclusions from this study are confirmed 
(as expected)" they are not apt to result in major 
changes in procurement or allocation policies. The dis-
parity between livers and the demand for them is too 
great to arbitrarily discard part of the supply. Ethical 
management of the scarce organ resource requires, 
first, the willingness to equitably (meaning randomly) 
share risk among the reeipient population rather than 
to cull donors, and, second, to aggressively resort to 
retransplantation in the event of primary failure. Even 
though the adverse effects on graft survival of female 
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gender and advancing age were seemingly unmistak-
able in our experience, these were not reflected in a 
major loss of patient life because of the effective use of 
secondary transplantation when needed. 
What to do with old female donors is the most prob-
lematic issue raised by this study. The high risk im-
posed by use of geriatric female livers raises the possi-
bility that these organs should be used only under 
circumstances that are adjudicated on a case-by-case 
basis, and recorded in a separate reporting category. 
For example, many centers in Europe and North 
America exclude from recipient candidacy patients who 
are human immunodeficiency virus-positive, hepatitis 
B virus carriers with evidence of DNA replication, and 
others with risk factors that predictably degrade pa-
tient and graft survival. Such patients would be better 
served by receiving old female livers than by receiving 
none at all. 
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